Queensland-based AnteoTech has received European accreditation for its 15-minute COVID-19 rapid test, to take the fight on the illness overseas. Their innovative, point-of-care COVID-19 antigen rapid test platform, EuGeni now has Conformitè Europëenne Mark registration, meaning it meets the health and safety rules in both the UK and Europe. The company will now start to commercialise their product in Australia, with the test based on their proprietary binding technology paired with global advancements in assay detection systems. The next step is gaining approval from the TGA in Australia to start the manufacturing process. | https://www.anteotech.com/announcements/test-platform-and-covid-19-test-receive-ce-mark-approval/
Ultrasound treatments could be the key to restoring memory function for people with Alzheimer's disease. A decade of research at the University of Queensland, through the Queensland Brain Institute, has led to a 12-month trial to determine whether ultrasound treatments are safe for patients with the disease. Brain institute researchers, led by Jurgen Gotz, have developed a fit-for-purpose ultrasound device to be used in the trial.The trial is underway at the university and Mater Hospital Brisbane, where a maximum of 12 people will receive four fortnightly treatments before a brain MRI scan and a cognitive test.More information: https://www.inkl.com/news/how-ultrasound-could-treat-alzheimer-s/lvmdLXupGJ
As technology is evolving work/life balance is becoming more stressful. Neuroscientists and technology professionals are working together with AI to make bots that act as individual counsellors, guides or coaches to help with mental health. They can start by asking questions like, "How are you feeling?" or "What's bothering you?"
IdeaSpies
Sabra Brock
